{"id":"NCT03719612","sponsor":"Lantheus Medical Imaging","briefTitle":"DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY","officialTitle":"A Phase III, Open-Label, Multicenter Trial to Evaluate Ejection Fraction, End-Diastolic and End-Systolic Volumes, by Unenhanced and DEFINITY速-Enhanced 2D-Echo and Magnetic Resonance Imaging","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-12-28","primaryCompletion":"2020-01-09","completion":"2020-01-09","firstPosted":"2018-10-25","resultsPosted":"2021-01-07","lastUpdate":"2021-01-28"},"enrollment":160,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Cardiac Disease"],"interventions":[{"type":"DRUG","name":"DEFINITY速","otherNames":[]}],"arms":[{"label":"DEFINITY速","type":"EXPERIMENTAL"}],"summary":"This is a Phase 3, prospective, open-label, multicenter study to evaluate Left Ventricular Ejection Fraction (LVEF) measurement accuracy and reproducibility of DEFINITY速 contrast-enhanced and unenhanced echocardiography as compared with non-contrast cardiac magnetic resonance imaging (CMR) used as the truth standard.","primaryOutcome":{"measure":"Absolute Value of LVEF Percentage Differences From CMR by Blinded Reader","timeFrame":"Up to 30 days between day of echocardiograms and CMR imaging","effectByArm":[{"arm":"Blinded Reader 1","deltaMin":5.7,"sd":4.292},{"arm":"Blinded Reader 2","deltaMin":5.88,"sd":4.33},{"arm":"Blinded Reader 3","deltaMin":5.03,"sd":3.548}],"pValues":[{"comp":"OG000","p":"0.358"},{"comp":"OG001","p":"0.804"},{"comp":"OG002","p":"0.371"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":15,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":160},"commonTop":[]}}